CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-26 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2016-06-22 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2016-06-22 | Friedman Mordechai Director | Grant or award · Stock Option (right to buy) | +16,666 | 16,666 | ||
| 2016-06-22 | Pinkas Alon Director | Grant or award · Stock Option (right to buy) | +15,333 | 15,333 | ||
| 2016-06-22 | Yablonka Uri Chief Operating Officer | Grant or award · Stock Option (right to buy) | +13,333 | 13,333 | ||
| 2016-06-22 | TAUB MALCOLM S Director | Grant or award | +8,666 | 17,332 | ||
| 2016-06-22 | SHORR ROBERT G L Director | Grant or award | +8,666 | 37,065 | ||
| 2015-12-16 | SHORR ROBERT G L Director | Sale | −10,800 | $2.71 | $29K | 28,399 |
| 2015-12-15 | TAUB MALCOLM S Director | Sale | −11,263 | $2.59 | $29K | 8,666 |
| 2015-12-14 | Friedman Mordechai Director | Option exercise | +5,000 | $0.75 | $4K | 5,000 |
| 2015-12-14 | Friedman Mordechai Director | Sale | −5,000 | $2.57 | $13K | 0 |
| 2015-12-14 | Friedman Mordechai Director | Option exercise · Stock Option (right to buy) | −5,000 | 11,666 | ||
| 2015-12-14 | TAUB MALCOLM S Director | Sale | −30,479 | $2.61 | $80K | 19,929 |
| 2015-12-11 | SHORR ROBERT G L Director | Sale | −5,300 | $2.56 | $14K | 39,199 |
| 2015-12-11 | TAUB MALCOLM S Director | Sale | −980 | $2.66 | $3K | 50,408 |
| 2015-12-10 | SHORR ROBERT G L Director | Sale | −5,500 | $2.71 | $15K | 44,499 |
| 2015-12-10 | TAUB MALCOLM S Director | Sale | −12,500 | $2.74 | $34K | 51,388 |
| 2015-12-01 | Bibring Yoram Chief Financial Officer | Returned to the company · Stock Option (right to buy) | +82,500 | 82,500 | ||
| 2015-10-01 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +2,000 | $2.58 | $5K | 138,806 |
| 2015-09-30 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +9,200 | $2.34 | $22K | 136,806 |
Page 9 of 14 · 274 trades